"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

Sarah Thordsen5 enrolled

Overview

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cardiogenic Shock Peripartum Cardiomyopathy Complication, Pregnancy

Interventions

Extracorporeal Membrane OxygenationDEVICE

Use of ECMO for circulatory / hemodynamic support of peripartum of pregnant patients who developed cardiogenic shock.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Female 2. Age 18 years or greater at the time of ECMO treatment. 3. Pregnant or within 6 months post-partum at the time of ECMO cannulation Exclusion Criteria: 1. No history of pregnancy. 2. No treatment with ECMO.

Locations (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Outcomes

Primary Outcomes

Clinical Outcome of Mother

Describe clinical course of pregnant or recently postpartum patients with cardiogenic shock treated with ECMO, including the rate of neonate survival

Time frame: Time of diagnosis -Six Month Survival Rate

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.